Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 1 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready
Cardinal Health 414 LLC has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 2 examiners but are contained within a single art unit, concentrating art-unit practice while retaining examiner variation.
SAMALA, JAGADISHWAR RAO is the busiest examiner, with 2 pending actions. Counsel should prioritize consistency across those related interactions and separately address the matter assigned to the other examiner.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| Double-patenting + other | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAMALA, JAGADISHWAR RAO | 2 | 67.9% | +55.7% |
| VU, JAKE MINH | 1 | 41.0% | +27.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17039409 | COMPOSITIONS AND RELATED METHODS FOR BLOCKING OFF-TARGET LOCALIZATION OF MANNOSYLATED DEXTRANS AND OTHER CD206 LIGANDS | SAMALA, JAGADISHWAR RAO | 80d overdue |
| 18189658 | Competitive Self-Blocking with Unlabeled Manocept Imaging Agents | VU, JAKE MINH | 12d |
| 17131087 | COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME | SAMALA, JAGADISHWAR RAO | — |
| Art Unit | Apps |
|---|---|
| 1618 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18189658 | Competitive Self-Blocking with Unlabeled Manocept Imaging Agents | VU, JAKE MINH | 1618 | §103 | Final Rejection | 12d | Pending | Mar 24, 2023 |
| 17131087 | COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME | SAMALA, JAGADISHWAR RAO | 1618 | §103 | Final Rejection | — | Pending | Dec 22, 2020 |
| 17039409 | COMPOSITIONS AND RELATED METHODS FOR BLOCKING OFF-TARGET LOCALIZATION OF MANNOSYLATED DEXTRANS AND OTHER CD206 LIGANDS | SAMALA, JAGADISHWAR RAO | 1618 | §103DP | Final Rejection | 80d overdue | Pending | Sep 30, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCardinal Health 414 LLC has 3 pending office actions as of October 2026, spread across 1 art units and 2 examiners.
Jagadishwar Rao Samala has the most, with 2 of Cardinal Health 414 LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
